Your browser doesn't support javascript.
loading
SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine.
Wang, Zu-Wei; Pan, Jing-Jing; Hu, Jian-Fei; Zhang, Jia-Qiang; Huang, Long; Huang, Yi; Liao, Cheng-Yu; Yang, Can; Chen, Zhi-Wen; Wang, Yao-Dong; Shen, Bai-Yong; Tian, Yi-Feng; Chen, Shi.
Afiliación
  • Wang ZW; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Pan JJ; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Hu JF; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Zhang JQ; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Huang L; Department of Hepatopancreatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China.
  • Huang Y; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China; Center for Experimental Research in Clinical Medicine, Fujian Provincial Hospital, Fuzhou 350001, China.
  • Liao CY; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Yang C; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Chen ZW; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China.
  • Wang YD; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China; Department of Hepatopancreatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China.
  • Shen BY; Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
  • Tian YF; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China; Department of Hepatopancreatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China. Electronic address: yifeng0887@126.com.
  • Chen S; Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou 350001, China; Department of Hepatopancreatobiliary Surgery, Fujian Provincial Hospital, Fuzhou 350001, China. Electronic address: wawljwalj@163.com.
Cell Rep ; 39(6): 110813, 2022 05 10.
Article en En | MEDLINE | ID: mdl-35545048
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / ARN Largo no Codificante Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cell Rep Año: 2022 Tipo del documento: Article País de afiliación: China